Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Maternal Stress Triggers Early-Life Eczema via Fetal Mast Cell Reprogramming [FetalMC-bulkRNAseq]

ABSTRACT: Maternal Stress Triggers Early-Life Eczema via Fetal Mast Cell Reprogramming [FetalMC-bulkRNAseq]

PROVIDER: PRJNA1134166 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR29766720_1.fastq.gz	Fastqsanger.gz
	SRR29766720_2.fastq.gz	Fastqsanger.gz
	SRR29766721_1.fastq.gz	Fastqsanger.gz
	SRR29766721_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Maternal Stress Triggers Early-Life Eczema via Fetal Mast Cell Reprogramming [DRG-bulkRNAseq]

Project description:Maternal Stress Triggers Early-Life Eczema via Fetal Mast Cell Reprogramming [DRG-bulkRNAseq]

| PRJNA1134741 | ENA

Maternal Stress Triggers Early-Life Eczema via Fetal Mast Cell Reprogramming [scRNAseq]

Project description:Maternal Stress Triggers Early-Life Eczema via Fetal Mast Cell Reprogramming [scRNAseq]

| PRJNA1135249 | ENA

Maternal Stress Triggers Early-Life Eczema via Fetal Mast Cell Reprogramming [10x Genomics Multiome ATAC + Gene Expression]

Project description:Maternal Stress Triggers Early-Life Eczema via Fetal Mast Cell Reprogramming [10x Genomics Multiome ATAC + Gene Expression]

| PRJNA1230230 | ENA

Skin biopsies from atopic eczema and healthy controls

Project description:The aim of this study was to find disease-associated genes in atopic eczema. Keywords: Skin biopsy, DNA microarray, atopic eczema

2006-10-13 | GSE6012 | GEO

Transcription profiling of human skin biopsies from atopic eczema and healthy controls

Project description:The aim of this study was to find disease-associated genes in atopic eczema. Experiment Overall Design: Skin biopsies were analyzed from ten patients with active atopic eczema and ten healthy controls.

2008-06-14 | E-GEOD-6012 | biostudies-arrayexpress

Blood single cell transcriptome of paradoxical eczema in psoriasis patients treated with biologics

Project description:Biologics targeting the tumour necrosis factor (TNF) and interleukin (IL)-17/23 axis are highly effective treatments for psoriasis but can result in cutaneous adverse events. The pathogenesis of paradoxical eczema, the occurrence of an atopic dermatitis phenotype after biologic initiation in people with psoriasis, is unknown. Using single cell RNA-seq and mass cytometry, we found increased expression of TNF, interferon (IFN)-γ and IFN-α and their signalling pathways in paradoxical eczema case cell clusters compared with matched psoriasis controls. Genetic variants influencing expression of TNF pathway genes were associated with paradoxical eczema in a separate genotyped cohort, and this association was independent of known atopic risk loci. This suggests that paradoxical eczema has a predominantly type 1 systemic inflammatory signature, and that genetic susceptibility to aberrant TNF pathway signalling could contribute to development of this phenotype during biologic treatment.

2025-05-16 | GSE246326 | GEO

Intra-individual genome expression analysis reveals a specific molecular signature of psoriasis and eczema

Project description:Comparing molecular signatures of psoriasis and eczema in patients co-affected by both diseases provides a comprehensive understanding of disease pathogenesis as well as a diagnostic tool to differentiate these widespread inflammatory skin diseases. In patients affected by both psoriasis and non-atopic or atopic eczema simultaneously (n=24), whole genome expression arrays of psoriasis, eczema, and non-involved skin were performed Arrays MQ_35 and MQ_41 did not pass quality control and thus were not normalized and were excluded from this Series.

2014-05-01 | E-GEOD-57225 | biostudies-arrayexpress

MicroRNA profiling of human healthy, psoriasis and atopic eczema skin samples

Project description:The microRNA expression profile of heathly, psoriasis and atopic eczema skin smaples was compared.

2007-08-16 | E-MEXP-1123 | biostudies-arrayexpress

Human connective tissue mast cell proteome

Project description:Mast cells are hematopoietic cells that reside preferentially in tissues exposed to internal and external environments. Mast cells sense immunological, inflammatory and environmental stimuli, and can be activated to release granules and generate inflammatory mediators. Mast cell-derived products confer protection against snake venoms and some parasite infections. Aberrant activation of mast cells is a major contributor to human pathology, including allergy, asthma and adverse drug reactions. Their strict tissue location has largely impeded the isolation of large numbers of primary mast cell for further analysis. To better understand the biology of mast cells, we analyzed the proteome of primary human and mouse mast cells by quantitative mass spectrometry. We identified a mast cell-specific protein signature that was conserved from mouse to man. Compared to a comprehensive set of other immune cell lineages, proteome analysis identified a unique and distant mast cell cluster. The mast cell signature included proteins governing granule biosynthesis and secretion, as well as proteoglycan- and neurotransmitter metabolism. Proteome conservation across species suggests evolutionary maintenance of mast cell functions.

2020-02-12 | PXD014978 | Pride

Mouse connective tissue mast cell proteome

2020-02-12 | PXD015040 | Pride